Andrew Croshaw is a Partner at Leavitt Partners, specializing in Health Care Practice, where he helps clients enter new markets, enhance the value of their products, navigate dynamic regulatory and reimbursement systems and improve health conditions around the world.

Previously, Mr. Croshaw served jointly as a Senior Executive Advisor to Secretary Michael O. Leavitt at the U.S. Department of Health and Human Services and as Project Leader for the Value-Driven Healthcare Initiative. In these roles Mr. Croshaw managed the overall implementation of the initiative, which aimed to improve the connectivity of America’s health information systems, encourage the measurement and availability of quality and price information, and enhance incentives for all healthcare stakeholders to seek high-quality, competitively-priced health care.

Prior to serving in the federal government, Mr. Croshaw worked at Novartis Pharmaceuticals Corporation where he focused on the Medicare and Medicaid business segments. Previous to this role, he held multiple leadership positions in payor marketing at Eli Lilly and Company where he coordinated pricing, rebate, and value-added program efforts aimed at preserving formulary access for flagship products among state Medicaid programs and private sector insurers.

Mr. Croshaw earned his master’s degree in business administration from Harvard University, where he pursued interests in healthcare innovation and leadership. He earned his bachelor’s degree from Utah State University where he served as Student Body President, University Trustee, and gubernatorial appointee to the Board of Regents for the Utah System of Higher Education.